🇺🇸 FDA
Patent

US 9815814

Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

granted A61PA61P11/00A61P11/02

Quick answer

US patent 9815814 (Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives) held by OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES”
Grant date
Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P11/00, A61P11/02, A61P11/04, A61P31/12